Clinical Trials Directory

Trials / Conditions / T-cell Lymphoblastic Lymphoma

T-cell Lymphoblastic Lymphoma

8 registered clinical trials studyying T-cell Lymphoblastic Lymphoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingAnti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma
NCT07300683
University College, LondonPhase 1
RecruitingA Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Ped
NCT06561074
M.D. Anderson Cancer CenterPhase 2
RecruitingCapizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphobl
NCT05681260
Children's Cancer Group, ChinaPhase 3
UnknownChimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL
NCT05554575
Bioceltech Therapeutics, Ltd.Phase 1
Enrolling By InvitationA Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
NCT05509855
Wugen, Inc.—
TerminatedXmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia
NCT05038644
Ehab L AtallahPhase 1
CompletedA Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
NCT02518113
Eli Lilly and CompanyPhase 1 / Phase 2
CompletedPilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignan
NCT00640796
St. Jude Children's Research HospitalPhase 1